EGFR-IN-173

CAT: 0013-GTR19273241-01Size: 50 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0013-GTR19273241-01Size:50 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

EGFR-IN-173 is an orally active, broad-spectrum mutant EGFR tyrosine kinase inhibitor that targets EGFR19del, L858R/T790M, and the triple mutation C797S, with an IC50 of 1.19 nM, effectively inhibiting the EGFR19del/T790M/C797S mutant. It demonstrates over 100-fold selectivity for mutated EGFR compared to the wild type [wild type IC50= 19.362 μM]. EGFR-IN-173 significantly suppresses cell migration, induces apoptosis in non-small cell lung cancer (NSCLC) cells, inhibits EGFR phosphorylation, and blocks downstream pathways (MAPK/ERK, AKT, STAT3) . It shows antitumor activity in NSCLC and Ba/F3 xenograft models and is applicable in NSCLC research.

Storage Conditions

-20°C

Notes

For research use only.

Related Products

Catalog	Name
GTR19210115-01	MAP3K14-IN-173
GTR19199148-01	HW 173
GTR19173967-01	HS-173
GTR19264167-01	ASX-173
GTR19160757-01	HS-173
GTR19262902-01	JYQ-173
GTR19209631-01	VS-II-173
GTR19262861-01	Antitumor agent-173
GTR19061723-01	CRAMP (140-173) (mouse)
GTR19230068-01	Antibiotic OM 173?2

Alternative Products

Catalog	Name
HY-175864	EGFR-IN-173
TRC-H671500-5MG	HS-173
HY-175282-01	ASX-173
MBS3603357-01	MAP3K14-IN-173
MBS5775234	HW 173
HY-163563-01	JYQ-173

EGFR-IN-173

Related Products

Alternative Products

Popular Products